Post-approval studies (Phase 4)Study completedNCT03688620
What this trial is testing
Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza Season
Who this might be right for
Influenza, Human
GlaxoSmithKline 1,060